Supplies of high-demand obesity treatments are improving, but that doesn’t mean it's easier to get them. Many employers and ...

This will be a “pivotal year,” one expert says, for GLP-1 drugs, which are massively disrupting the benefits landscape.

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

Eli Lilly says new research shows its medication Zepbound helped patients shed more weight over a shorter period of time than Novo Nordisk’s Wegovy. The Biden administration has proposed a new rule to ...